课题基金 / 基金详情

MOLECULAR MECHANISMS OF PML MEDIATED GROWTH CONTROL

MOLECULAR MECHANISMS OF PML MEDIATED GROWTH CONTROL
PML 介导的生长控制的分子机制
批准号:
6905379
负责人:
KATHERINE L B BORDEN
金额:
$2.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-01-05 至 2005-12-31

项目摘要

项目成果

KATHERINE L B BORDEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the investigator's abstract) The promyelocytic leukemia protein PML is ascribed roles in growth control, transformation suppression and cell death but its mechanism of action remains enigmatic. These actions are closely tied to the subcellular localization of the protein. In normal cells, the majority of PML forms nuclear bodies, which are modulated by stress. PML nuclear bodies are heterogeneous multiprotein complexes that are found in all normal cell types studies suggesting that they play a basic role in mammalian cells. The t(15;17) disrupts PML in acute promyelocytic leukemia (APL) resulting in loss of PML nuclear bodies. Subsequent disruptions of PML's growth control and apoptotic action are thought to contribute to leukemogenesis. PML is disrupted in other pathogenic conditions such as spinocerebellar ataxia, and by several viruses including papilloma and Herpes. To determine a molecular function for PML, Dr. Borden identified nuclear body components likely to be of physiological relevance. These components include eukaryotic translation initiation factor (4E (eKF-4E) and the proline-rich homeodomain protein PRH. In addition, PRH and eIF-4E interact. Her data suggest that PML acts in the regulation of transport of selected mRNAs. This action is modulated through an interaction between PML and eIF-4E, a protein with established functions in RNA transport. She has shown that transport of cyclin D1 mRNA is preferentially suppressed by PML presenting a possible mechanism for PML's growth suppression activity. EIF-4E is mitrogenic and induces oncogenic transformation suggesting that association of this protein with PML in the nucleus may be related to PML's growth control functions. PRH is required for myeloid development. Thus, the PRH-PML interaction may represent a link between growth control and differentiation. She hypothesizes that PML executes its growth suppression actions through association with other cellular partners, e.g. eIF-4E and PRH, by regulating RNA transport selectively. She proposes to: (1) Investigate the RNA transport activities of PML, and ascertain whether this function is related to its growth suppression action, (2) Determine whether PRH modulates RNA transport actions mediated by PML and PML's growth suppression action, and (3) Investigate the PML/PRH interaction using high-resolution NMR method to elucidate the basis of this interaction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms of eIF4E mediated transformation
  • 批准号:
    10295914
  • 项目类别:
  • 资助金额:
    $29.35万
  • 财政年份:
    2003
  • 负责人:
    KATHERINE L B BORDEN
  • 依托单位:
Mechanisms of elF4E mediated transformation
  • 批准号:
    7093099
  • 项目类别:
  • 资助金额:
    $21.09万
  • 财政年份:
    2003
  • 负责人:
    KATHERINE L B BORDEN
  • 依托单位:
Molecular Mechanisms of eIF4E mediated transformation.
  • 批准号:
    7890484
  • 项目类别:
  • 资助金额:
    $22.16万
  • 财政年份:
    2003
  • 负责人:
    KATHERINE L B BORDEN
  • 依托单位:
Mechanisms of elF4E mediated transformation
  • 批准号:
    6953013
  • 项目类别:
  • 资助金额:
    $21.6万
  • 财政年份:
    2003
  • 负责人:
    KATHERINE L B BORDEN
  • 依托单位:
国内基金
海外基金
欣胃颗粒调控Cyclins-CDKs-CKIs细胞周期网络抑制胃癌前病变细胞增殖的分子机制研究
  • 批准号:
    81973601
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    张杨
  • 依托单位:
Med19-cyclins信号通路在骨肉瘤增殖中的作用研究
  • 批准号:
    81502325
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2015
  • 负责人:
    余文熙
  • 依托单位:
无/低cyclins肿瘤细胞群(NCCCs):一种新的肿瘤细胞亚群?
  • 批准号:
    81171927
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2011
  • 负责人:
    龚建平
  • 依托单位:
CYCLINS/CDK分子靶点的建立与抗癌药物筛选
  • 批准号:
    30100227
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2001
  • 负责人:
    王鸿鹤
  • 依托单位: